Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy

Clinical trial NCT03081143 · COMPLETED

Trial details

NCT number

NCT03081143

Sponsor

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Status

COMPLETED

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2017-05-10

Primary completion

2026-05-04

Enrollment

429

View on ClinicalTrials.gov